Elevation of S100 calcium binding protein A9 in sputum of neutrophilic inflammation in severe uncontrolled asthma
- Authors
- Lee, Tae-Hyeong; Jang, An-Soo; Park, Jong-Sook; Kim, Tae-Hoon; Choi, Young Suk; Shin, Hye-rim; Park, Sung-Woo; Uh, Soo-Taek; Choi, Jae-Sung; Kim, Young Hoon; Kim, YongBae; Kim, Sungryul; Chung, Il Yup; Jeong, Sung Hwan; Park, Choon-Sik
- Issue Date
- Oct-2013
- Publisher
- American College of Allergy, Asthma, & Immunology
- Citation
- Annals of Allergy, Asthma and Immunology, v.111, no.4, pp.268 - U116
- Indexed
- SCIE
SCOPUS
- Journal Title
- Annals of Allergy, Asthma and Immunology
- Volume
- 111
- Number
- 4
- Start Page
- 268
- End Page
- U116
- URI
- https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/26786
- DOI
- 10.1016/j.anai.2013.06.028
- ISSN
- 1081-1206
- Abstract
- Background: Neutrophilic airway inflammation is frequently observed in severe uncontrolled asthma (UA) and controlled asthma (CA). However, there is no sputum biomarker to differentiate the 2 conditions. Objective: To identify biomarkers of severe uncontrolled asthma with neutrophilic airway inflammation. Methods: Sputum with a neutrophil content larger than 70% was pooled from 5 patients with severe UA and from 10 patients with CA. Two-dimensional electrophoresis was adopted for differential display proteomics, and candidate proteins were identified using matrix-assisted laser adsorption/ionization-time of flight mass spectrometric analysis. S100 calcium binding protein A9 (S100A9) was identified by western blot and its level was measured in sputum from asthmatics with varying disease severity, patients with chronic obstructive lung disease, and normal controls using enzyme-linked immunosorbent assay. Results: Fourteen protein spots exhibited differences in relative intensity between patients with severe UA and those with CA. Matrix-assisted laser adsorption/ionizationetime of flight/time of flight of these spots showed an increase in human neutrophil peptide-2, S100A9, b-amylase, neutrophil gelatinase-associated lipocalin, 4-aminobutyrate transaminase, and cystatin SA in patients with UA compared with patients with CA. There was a decrease in the plunc precursor, complement C3 component, immunoglobulin heavychain variable region, glial fibrillary acidic protein isoform-1, IgM kIIIb SON, MLL-AF4 der(11) fusion protein, cytokeratin-8, and recombinant IgG4 heavy chain. S100A9 was detected at a higher level in western blots of neutrophilic sputum from patients with severe UA vs CA. S100A9 levels were significantly increased, as measured by enzyme-linked immunosorbent assay, in neutrophilic UA compared with CA, eosinophilic UA and CA, and chronic obstructive lung disease. Conclusion: S100A9 in sputum may be a biomarker of neutrophilic inflammation in severe UA. (C) 2013 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
- Files in This Item
-
Go to Link
- Appears in
Collections - COLLEGE OF SCIENCE AND CONVERGENCE TECHNOLOGY > ERICA 의약생명과학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.